MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second… Dec 16, 2021
atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s… Dec 16, 2021
Traditional Commerce Companies Flocking To OOOOO Entertainment’s Interactive Shopping Model Dec 15, 2021
MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application Dec 15, 2021
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine)… Dec 15, 2021
Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights Dec 15, 2021
